{"id":"W2151252098","doi":"10.1016/s0140-6736(09)60734-0","title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial","year":2009,"lang":"en","type":"article","venue":"The Lancet","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":979,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre; McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Venography; Pulmonary embolism; Surgery; Deep vein; Arthroplasty; Thrombosis; Population; Venous thrombosis; Anesthesia; Internal medicine; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02968918783262197,"score_gpt":0.2908447177962884,"score_spread":0.2611555299636664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}